MEHMET AKCE

Associate Professor

The University of Alabama

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Mehmet Akce is an Associate Professor at the University of Alabama at Birmingham, United States. His research primarily focuses on oncology, particularly in the areas of pancreatic ductal adenocarcinoma, biliary tract cancers, and HER2 alterations across solid tumors. Dr. Akce has contributed to numerous recent publications, including studies on innovative therapies and clinical practice guidelines in oncology.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Julienne Carstens

University of Alabama, Tuscaloosa

UNITED STATES

View details

Darryl Outlaw

The University of Alabama

UNITED STATES

View details

Yu-Hua Fang

University of Alabama, Tuscaloosa

UNITED STATES

View details

Wei Zheng

Assistant Professor

Emory University

UNITED STATES

View details

Smith Giri

The University of Alabama

UNITED STATES

View details

Aakash Desai

University of Alabama, Tuscaloosa

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

MEHMET AKCE

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

HER2 alterations across solid tumors: implications for comprehensive testing

ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma

Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology

Phase II study of avelumab and trastuzumab with FOLFOX chemotherapy in previously untreated HER2-amplified metastatic gastroesophageal adenocarcinoma

330P Real-world treatment (tx) outcomes of durvalumab (D)-based regimens in advanced biliary tract cancer (aBTC): LIVER-R interim analysis (IA)

410P Comprehensive molecular and immunological characterization of CLDN18.2 in esophageal and esophagogastric junction carcinoma (EEJC)

Building a community-academic partnership to improve clinical trial access in southern Alabama.

Dual targets, singular promise: A comprehensive analysis of bispecific antibodies in solid tumor oncology.

Abstract 1695: Paricalcitol plus hydroxychloroquine enhances gemcitabine activity and induces mesenchymal to epithelial transition in pancreatic ductal adenocarcinoma

Abstract 2026: Comprehensive molecular and immunological characterization of CLDN18.2 in pancreatic cancer

Association of emotional support with quality of life, mental health, and survival in older adults with gastrointestinal malignancies–Results from the CARE registry

Evolving Role of Immunotherapy in Advanced Biliary Tract Cancers

Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors

Successful Liver Transplantation of Recurrent Fibrolamellar Carcinoma following Clinical and Pathologic Complete Response to Triple Immunochemotherapy: A Case Report

Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single‐arm, phase 2 study

Is adjuvant chemotherapy beneficial for stage II-III goblet cell carcinoid/goblet cell adenocarcinoma of the appendix?

Survival outcome of adjuvant chemotherapy in deficient mismatch repair stage III colon cancer

Nonbacterial Thrombotic Endocarditis and Widespread Skin Necrosis in Newly Diagnosed Lung Adenocarcinoma

Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials

Collaborators (6)

Julienne Carstens

Darryl Outlaw

Yu-Hua Fang

Wei Zheng

Smith Giri

Aakash Desai

Make your next move.